Literature DB >> 18336326

Synthesis and cytotoxicity studies of new morpholino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs.

M Hogan1, J Claffey, C Pampillón, M Tacke.   

Abstract

From the carbolithiation of 6-morpholino fulvene (3) and different lithiated nitrogen containing heterocycles (2-N-methylimidazolyl, 2-N-(N,N-dimethylamino)methyl-imidazolyl, and 2-N-methylindolyl), the corresponding lithium cyclopentadienide intermediate (4a-c) was formed. These three lithiated intermediates underwent a transmetallation reaction with TiCl(4) resulting in morpholino-functionalised titanocenes 5a-c. When these titanocenes were tested against LLC-PK cells, the IC(50) values obtained were of 24, 36, and 41 microM respectively. The most cytotoxic titanocene in this paper (5a) with an IC(50) value of 24 microM is found to be almost ten times less cytotoxic than cis-platin, which showed an IC(50) value of 3.3 microM when tested on the epithelial pig kidney LLC-PK cell line, and approximately 2 times less cytotoxic than its dimethylamino-functionalised analogue. Encouragingly however, the IC(50) value obtained for titanocene 5a is approximately 100 times better than titanocene dichloride itself.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336326     DOI: 10.2174/157340608783789202

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  2 in total

1.  A proposed mechanism for the inhibitory effect of the anticancer agent titanocene dichloride on tumour gelatinases and other proteolytic enzymes.

Authors:  Maria Pavlaki; Katerina Debeli; Irene-Eva Triantaphyllidou; Nikolaos Klouras; Eleftheria Giannopoulou; Alexios J Aletras
Journal:  J Biol Inorg Chem       Date:  2009-04-24       Impact factor: 3.358

2.  Ability of Group IVB metallocene polyethers containing dienestrol to arrest the growth of selected cancer cell lines.

Authors:  Michael R Roner; Charles E Carraher; Kimberly Shahi; Yuki Ashida; Girish Barot
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.